
William P. Watkins Iii
Examiner (ID: 11932, Phone: (571)272-1503 , Office: P/1783 )
| Most Active Art Unit | 1783 |
| Art Unit(s) | 1773, 1751, 1783, 1508, 1772, 1723, 1794, 1315, 1754 |
| Total Applications | 2062 |
| Issued Applications | 1212 |
| Pending Applications | 105 |
| Abandoned Applications | 752 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19242099
[patent_doc_number] => 12012519
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-18
[patent_title] => Liquid-liquid phase separation driven protein-based underwater adhesive coatings
[patent_app_type] => utility
[patent_app_number] => 17/169581
[patent_app_country] => US
[patent_app_date] => 2021-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 35
[patent_no_of_words] => 4853
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 234
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169581
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/169581 | Liquid-liquid phase separation driven protein-based underwater adhesive coatings | Feb 7, 2021 | Issued |
Array
(
[id] => 16855169
[patent_doc_number] => 20210155914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => IMPROVED ENDOINULINASES
[patent_app_type] => utility
[patent_app_number] => 17/163521
[patent_app_country] => US
[patent_app_date] => 2021-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8898
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17163521
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/163521 | Endoinulinases | Jan 30, 2021 | Issued |
Array
(
[id] => 20077753
[patent_doc_number] => 12351806
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-08
[patent_title] => HMO production
[patent_app_type] => utility
[patent_app_number] => 17/759261
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 8248
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759261
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/759261 | HMO production | Jan 21, 2021 | Issued |
Array
(
[id] => 20563066
[patent_doc_number] => 12565669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-03
[patent_title] => Optimized process for producing second-generation sugars and fermentation products
[patent_app_type] => utility
[patent_app_number] => 17/797216
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 0
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17797216
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/797216 | Optimized process for producing second-generation sugars and fermentation products | Jan 21, 2021 | Issued |
Array
(
[id] => 18299975
[patent_doc_number] => 20230109661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => HMO PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 17/759275
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759275
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/759275 | HMO PRODUCTION | Jan 21, 2021 | Issued |
Array
(
[id] => 20687895
[patent_doc_number] => 12618032
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-05
[patent_title] => Method for producing organic substance and device for producing organic substance
[patent_app_type] => utility
[patent_app_number] => 17/794447
[patent_app_country] => US
[patent_app_date] => 2021-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3670
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17794447
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/794447 | Method for producing organic substance and device for producing organic substance | Jan 20, 2021 | Issued |
Array
(
[id] => 16963215
[patent_doc_number] => 20210214714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => CBLB ENDONUCLEASE VARIANTS, COMPOSITIONS, AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/150293
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47373
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17150293
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/150293 | CBLB endonuclease variants, compositions, and methods of use | Jan 14, 2021 | Issued |
Array
(
[id] => 18198384
[patent_doc_number] => 20230051903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => FERMENTATION METHOD
[patent_app_type] => utility
[patent_app_number] => 17/758908
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14734
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17758908
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/758908 | FERMENTATION METHOD | Jan 14, 2021 | Pending |
Array
(
[id] => 19166045
[patent_doc_number] => 11981935
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-14
[patent_title] => 7b-hydroxysteroid dehydrogenase mutants and process for the preparation of ursodeoxycholic acid
[patent_app_type] => utility
[patent_app_number] => 17/150243
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 50
[patent_no_of_words] => 32322
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17150243
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/150243 | 7b-hydroxysteroid dehydrogenase mutants and process for the preparation of ursodeoxycholic acid | Jan 14, 2021 | Issued |
Array
(
[id] => 18485300
[patent_doc_number] => 20230212634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => Expression of Ovalbumin and its Natural Variants
[patent_app_type] => utility
[patent_app_number] => 17/791940
[patent_app_country] => US
[patent_app_date] => 2021-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26416
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17791940
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/791940 | Expression of Ovalbumin and its Natural Variants | Jan 13, 2021 | Abandoned |
Array
(
[id] => 16824537
[patent_doc_number] => 20210139830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => Growth of Bacterial Host Cells in Gas Permeable Low-Density Polyethylene Bags for Production of Plasmid DNA or Recombinant Molecules
[patent_app_type] => utility
[patent_app_number] => 17/146023
[patent_app_country] => US
[patent_app_date] => 2021-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17146023
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/146023 | Growth of bacterial host cells in gas permeable low-density polyethylene bags for production of plasmid DNA or recombinant molecules | Jan 10, 2021 | Issued |
Array
(
[id] => 20453303
[patent_doc_number] => 12516355
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Production of mono-ethylene glycol
[patent_app_type] => utility
[patent_app_number] => 17/792987
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 3682
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 280
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17792987
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/792987 | Production of mono-ethylene glycol | Jan 7, 2021 | Issued |
Array
(
[id] => 18497752
[patent_doc_number] => 20230220438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => COMPOSITIONS AND METHODS FOR AUTO-INDUCIBLE CELLULAR LYSIS AND NUCLEOTIDE HYDROLYSIS
[patent_app_type] => utility
[patent_app_number] => 17/758477
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17758477
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/758477 | COMPOSITIONS AND METHODS FOR AUTO-INDUCIBLE CELLULAR LYSIS AND NUCLEOTIDE HYDROLYSIS | Jan 7, 2021 | Pending |
Array
(
[id] => 20771790
[patent_doc_number] => 12655452
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-16
[patent_title] => Methods and compositions for enhanced ethanol production
[patent_app_type] => utility
[patent_app_number] => 17/791095
[patent_app_country] => US
[patent_app_date] => 2021-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9980
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17791095
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/791095 | Methods and compositions for enhanced ethanol production | Jan 6, 2021 | Issued |
Array
(
[id] => 18295417
[patent_doc_number] => 20230105103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => THERAPEUTIC MOLECULES FOR COMBATING SEPSIS
[patent_app_type] => utility
[patent_app_number] => 17/789381
[patent_app_country] => US
[patent_app_date] => 2020-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9460
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17789381
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/789381 | THERAPEUTIC MOLECULES FOR COMBATING SEPSIS | Dec 25, 2020 | Abandoned |
Array
(
[id] => 18158968
[patent_doc_number] => 20230025560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => PROCESS FOR THE PRODUCTION OF MYCOPROTEIN
[patent_app_type] => utility
[patent_app_number] => 17/785979
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11773
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17785979
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/785979 | PROCESS FOR THE PRODUCTION OF MYCOPROTEIN | Dec 17, 2020 | Abandoned |
Array
(
[id] => 18160540
[patent_doc_number] => 20230027132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => BINDING PROTEINS FOR THE ENZYME ACID ALPHA GLUCOSIDASE (GAA) AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/786885
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7990
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786885
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786885 | Binding proteins for the enzyme acid alpha glucosidase (GAA) and uses thereof | Dec 16, 2020 | Issued |
Array
(
[id] => 16901119
[patent_doc_number] => 20210180035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => COMPOSITIONS COMPRISING A MODIFIED GIcNAc-1-PHOSPHOTRANSFERASE AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/125480
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17125480
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/125480 | Compositions comprising a modified GIcNAc-1-phosphotransferase and methods of use thereof | Dec 16, 2020 | Issued |
Array
(
[id] => 18545313
[patent_doc_number] => 11718653
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Method for in vitro glycoengineering of an erythropoiesis stimulating protein
[patent_app_type] => utility
[patent_app_number] => 17/124254
[patent_app_country] => US
[patent_app_date] => 2020-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 7
[patent_no_of_words] => 8834
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17124254
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/124254 | Method for in vitro glycoengineering of an erythropoiesis stimulating protein | Dec 15, 2020 | Issued |
Array
(
[id] => 18932519
[patent_doc_number] => 11884927
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Fusion constructs as protein over-expression vectors
[patent_app_type] => utility
[patent_app_number] => 17/119670
[patent_app_country] => US
[patent_app_date] => 2020-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 17823
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17119670
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/119670 | Fusion constructs as protein over-expression vectors | Dec 10, 2020 | Issued |